Shares of Akero Therapeutics AKRO skyrocketed 105.7% in a week after the company announced initial positive top line 96-week data from a mid-stage study of its lead product candidate, efruxifermin ...

J.P. Morgan analyst Eric Joseph maintained a Buy rating on Akero Therapeutics (AKRO – Research Report) on January 27 and set a price target of $73.00. The company’s shares closed yesterday at ...

In this article, we are going to take a look at where Akero Therapeutics Inc. (NASDAQ:AKRO) stands against the other stocks. Wall Street ended the first trading day of the week on a mixed note ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Sophie Hessekiel is a Newsweek writer based in Los Angeles. Her focus is on celebrity news and entertainment. She has also written extensively about culture and relationships for a variety of ...

The rare southern snow was the product of a confluence of events that included cold Arctic air colliding with abundant ocean moisture, somewhat akin to a Gulf of Mexico version of what ...

A rare planetary alignment, which will see six planets line up in a row across the night sky, is due to take place from tonight for the first time since 2018. Also known as a 'planet parade', it ...